CASI PHARMACEUTICALS, INC. Accounts Payable and Other Accrued Liabilities, Current
CASI PHARMACEUTICALS, INC. (CASIF) had Accounts Payable and Other Accrued Liabilities, Current of $24.17 million as of 2025-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Notes › Payables and Accruals
us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent · last filed 2026-05-15
- 2025-12-31: Accounts Payable and Other Accrued Liabilities, Current $24.17M.
- 2024-12-31: Accounts Payable and Other Accrued Liabilities, Current $15.34M.
- 2023-12-31: Accounts Payable and Other Accrued Liabilities, Current $12.29M.
- 2022-12-31: Accounts Payable and Other Accrued Liabilities, Current $11.82M.
| Period end | Accounts Payable and Other Accrued Liabilities, Current |
|---|---|
| 2025-12-31 | $24.17M 20-F · filed 2026-05-15 |
| 2024-12-31 | $15.34M 20-F · filed 2026-05-15 |
| 2023-12-31 | $12.29M 20-F · filed 2025-03-31 |
| 2022-12-31 | $11.82M 20-F · filed 2024-03-28 |
| 2021-12-31 | $10.96M 20-F · filed 2023-04-26 |